BeOne Medicines Ltd.SSE: 688235

2024 Annual Report

Apr 29, 2025 · Issued by BeOne Medicines Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 29, 2025

On 6ix: 6ix.com/news/2024-annual-report-180

2024 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

BeOne Medicines Ltd. on 6ix

Earlier from BeOne Medicines

Announcement on Convening the 2024 Annual Performance BriefingApr 19, 2025
BeiGene to Announce First Quarter 2025 Financial Results on May 7Apr 17, 2025
Notice on Convening the 2025 Annual General MeetingApr 8, 2025
BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development ProgramApr 3, 2025
BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung CancerMar 31, 2025

Later from BeOne Medicines

All BeOne Medicines news releases

Follow BeOne Medicines into a list and get an email when it puts out news.

Follow BeOne Medicines